Publications by authors named "Celine Colin"

Claim this Profile
S
Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study.
Maja Jahnmatz, Laura Richert, Nabil Al-Tawil, Jann Storsaeter, Céline Colin

Lancet Infect Dis· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study.
Linda Wittkop, Julie Arsandaux, Ana Trevino, Maarten Schim van der Loeff, Jane Anderson, Celine Colin

J Antimicrob Chemother· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe morbidity according to sex in the era of combined antiretroviral therapy: the ANRS CO3 Aquitaine Cohort.
Mojgan Hessamfar, Céline Colin, Mathias Bruyand, Madeleine Decoin, Fabrice Bonnet

PLoS One· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of baseline HIV-1 DNA level in highly-experienced patients receiving raltegravir, etravirine and darunavir/ritonavir regimen (ANRS139 TRIO trial).
Charlotte Charpentier, Catherine Fagard, Céline Colin, Christine Katlama, Jean-Michel Molina

PLoS One· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous versus intermittent treatment strategies during primary HIV-1 infection: the randomized ANRS INTERPRIM Trial.
Cécile Goujard, Dominique Emilie, Caroline Roussillon, Véronique Godot, Christine Rouzioux, Céline Colin

AIDS· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial.
Catherine Fagard, Céline Colin, Charlotte Charpentier, Agathe Rami, Christine Jacomet

J Acquir Immune Defic Syndr· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.
Linda Wittkop, Huldrych F Günthard, Frank de Wolf, David Dunn, Alessandro Cozzi-Lepri, Céline Colin

Lancet Infect Dis· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of triple-class virological failure in children with HIV: a retrospective cohort study.

Lancet· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen.
Charlotte Charpentier, Bénédicte Roquebert, Céline Colin, Anne-Marie Taburet, Catherine Fagard

AIDS· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients.
Aurélie Barrail-Tran, Yazdan Yazdanpanah, Lauriane Goldwirt, Geneviève Chêne, Céline Colin

AIDS· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stimulation of the primary anti-HIV antibody response by IFN-alpha in patients with acute HIV-1 infection.
Laura Adalid-Peralta, Véronique Godot, Céline Colin, Roman Krzysiek, Thi Tran

J Leukoc Biol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis